Cargando…
Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis
BACKGROUND: Since the outbreak of coronavirus disease 2019 (COVID-19) in China, numerous research institutions have invested in the development of anti-COVID-19 vaccines and screening for efficacious drugs to manage the virus. OBJECTIVE: To explore the potential targets and therapeutic drugs for the...
Autores principales: | Tan, Siyou, Chen, Wenyan, Xiang, Hongxian, Kong, Gaoyin, Zou, Lianhong, Wei, Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797890/ https://www.ncbi.nlm.nih.gov/pubmed/33428154 http://dx.doi.org/10.1007/s13258-020-01021-8 |
Ejemplares similares
-
ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022) -
Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015) -
Druggable targets and therapeutic development for COVID-19
por: Duan, Xiaohua, et al.
Publicado: (2022) -
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
por: Yang, Dan, et al.
Publicado: (2020) -
An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
por: Radusky, Leandro G, et al.
Publicado: (2015)